Skip to main content
logo
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.46
+0.18 (2.87%)
At close: Oct 27, 2026, 4:00 PM EDT
6.46
0.00 (0.00%)
After-hours: Oct 27, 2026, 4:00 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Research and Development of Cell Therapy Product Candidates
2.80M38.91M26.00M110.78M85.08M
Total
2.80M38.91M26.00M110.78M85.08M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
2.80M38.91M26.00M110.78M85.08M
Total
2.80M38.91M26.00M110.78M85.08M